To evaluate whether inhibition of PI3K can serve as an effective therapeutic strategy in attenuating BCC tumors, we generated BCC tumors in the Ptch1fl/fl; Gli1-CreERT2 mouse model and intraperitoneally injected either DMSO or 10 mg/kg of BKM120 daily for seven days. Here, GLI1 is linked to skin basal cell carcinoma.